Some clinical researches also evidenced this association between the BDNF Met carrier and lower BDNF levels in the patients with major depressive disorder (37), schizophrenia, and bipolar disorder (38) respectively, suggesting the Met allele may play a key role in regulating BDNF protein expression (39). Here, BDNF is linked to major depressive disorder.